AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

572.657

-9.618-1.65%

Number of Gainers:6

Number of Losers:20

Number of Flat:19

PE:- -

High:582.438

Open:576.644

Low:571.321

Close:582.275

Volume:51.60M

Turnover:135.68M

Market Cap:78.73B

Float Cap:75.96B

Loading ...

Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading

MT Newswires Live

Skillful Craftsman Unit Signs 12-Month CSL AI Service Deal With China Auto Insurance Firm

Neuren's Royalties From Daybue Sales Beat Bull's Forecast -- Market Talk

Arcturus Therapeutics Q4 net loss narrows

Analog Devices Inc Stock Opened Down by 3.38% on Mar 3: Key Drivers Unveiled

Arista Networks Inc Stock Opened Down by 3.07% on Mar 3: A Full Analysis

PAR Technology Launches Artificial Intelligence Suite for Convenience Retailers

MT Newswires Live

Pfisterer posts FY 2025 order backlog of EUR 335 million, up more than 40%

BUZZ-Australia's Neuren Pharmaceuticals drops as US partner seeks EMA re-examination

Neuren Partner Plans to Request Re-examination of European Authority's Opinion on Trofinetide Marketing Authorization Application

MT Newswires Live

Immuron HY26 net loss narrows 22.9% to AUD 1.9 million

Indonesia's Soekarno-Hatta Reschedules 39 Middle East Flights

How Investors May Respond To Neuren Pharmaceuticals (ASX:NEU) 2025 Results, Buy-Back Plan And Pipeline Progress

Simply Wall St.

Opthea Swings to Fiscal H1 Earnings, Posts Lower Revenue, Plans to Rename

MT Newswires Live

Organic Growth in Australia's Healthcare Services Likely Due to Increased Availability of Bulk-Billing General Practitioners, Jefferies Says

MT Newswires Live

Anagenics Ltd-an1 - Director Appointment

THOMSON REUTERS

Opthea Ltd H1 Net Income AUD 339.9 Million

THOMSON REUTERS

17 Jakarta-Mideast Flights Canceled Due to Airspace Closure; Here's the List

Four Flights at Bali Airport Affected by US Attack on Iran

Neuren Pharmaceuticals FY 2025 Margin Strength Tests Earnings Quality Concerns

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7508/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":572.65656,"timestamp":1772600399881,"preClose":582.2749,"halted":0,"volume":51597816,"delay":0,"changeRate":-0.016519,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-9.618347,"latestTime":"03-04 16:00:00 AEDT","open":576.6438,"high":582.43805,"low":571.3208,"amount":135681694,"amplitude":0.019093,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772665200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1772578800000,1772600400000]],"turnoverRate":0.001982,"increases":8,"decrements":19,"flats":16,"marketCap":78730906752.25,"floatMarketCap":75961049390.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":582.43805,"amplitude":0.019093,"preClose":582.2749,"low":571.3208,"latestPrice":572.65656,"volume":51597816,"delay":0,"open":576.6438,"prevYearClose":644.3692,"prevWeekClose":592.49,"prevMonthClose":592.49,"prevQuarterClose":644.369,"fiveDayClose":587.206,"twentyDayClose":678.235,"sixtyDayClose":677.502,"secType":"PLATE","market":"AU","turnoverRate":0.001982,"marketCap":78730906752.25,"floatMarketCap":75961049390.5,"timestamp":1772600399881,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":6,"down":20,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616551077","title":"Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2616551077","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616551077?lang=en_us&edition=fundamental","pubTime":"2026-03-04 23:38","pubTimestamp":1772638709,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were modestly higher Wednesday morning, rising 0.30% to 2,790.11 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by consumer lended Eason Technology  and computer hardware maker Canaan , which climbed 19% and 9%, respectively. They were followed by diagnostic imaging centers company Concord Medical Services  and biopharmaceutical firm Zai Lab , which advanced 7.3% and 6.4%, respectively.The decliners from North Asia were led by thin-film liquid display maker LG Display  and fintech firm AMTD Digital , which dropped 9% and 4.9% respectively. They were followed by lender CNFinance  and automotive marketplace Cango , which lost 3% and 1.8% respectively.From South Asia, the gainers were led by IT firms Sify Technologies  and Infosys , which rose 4.3% and 1.6% respectively. They were followed by pharmaceutical company Dr. Reddy's Laboratories  and tech conglomerate Sea , which were up 0.7% and 0.6% respective","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861220207.SGD","BK7095","BK4523","LU0979878070.USD","LU0143863198.USD","LU0868486357.SGD","LU1323998911.USD","LU0791590937.USD","LU0516422366.SGD","CAN","LU0823039010.USD","BK4139","LU0289960550.SGD","LU0516422440.USD","HKD","BK7508","LU0541501648.USD","BK4132","LU2045819591.USD","LU1805238398.USD","BK4526","LU0251143029.SGD","BK4122","IE00B3M56506.USD","LU0589944569.HKD","LU0572939691.SGD","BK4535","SG9999013478.USD","BK4220","LU0821914370.USD","LU2065171311.SGD","LU0348788117.USD","BK4134","SG9999004220.SGD","LU2087589342.USD","BK4595","BK7096","BK4518","BK4207","LU0066902890.USD","LU0210637038.USD","IE0001KFT4U8.USD","BK4503","IE0034224299.USD","LU2125910849.SGD","BK4581","LU0231203729.USD","LU2065170008.USD","LU0862451753.SGD","LU0898667661.SGD","TLK","LU1839390173.USD","BK4115","BK4214","LU0264410563.USD","LU1242518931.SGD","LU1366334578.USD","LU0541502299.USD","PHI","LU1868837565.USD","BK4533","LU0572940350.SGD","LU0791591158.USD","SG9999014484.SGD","LU0345776255.USD","RDY","LU0264606111.USD","LU0251143458.SGD","LU1861217088.USD","LU0143863784.USD","SG9999013460.SGD","LU0164881194.USD","BK4196","BK4085","WIT","LU1508157978.USD","LU2152927971.USD","IE00BYTNYM70.SGD","LU0175139822.USD","09688","BK4170","BK4588","BK7016","LU0708995666.HKD","LU1804176565.USD","LU1102505929.USD","LU1481012133.USD","LU2543165471.USD","IE00BD6J9T35.USD","BK4164","BK4532","CNF","LU2125910500.SGD","BK4148","LU0499858438.USD","LU2065169927.USD","BK4117","LU2265009873.SGD","BK4548","LU0531971678.HKD","LU0828237940.HKD","SG9999002414.USD","LU0441851309.USD","LU0072462343.USD","LU0307460401.USD","LU0516422952.EUR","LU1048596156.SGD","LU2238330802.EUR","INFY","BK4596","LU0737861269.HKD","LU0048575426.USD","LU0248272758.USD","BK4585","SG9999001135.SGD","LU1242518857.USD","LU2488822045.USD","SG9999002406.SGD","IE0031814969.USD","SG9999002620.SGD","LU1868837722.USD","BK4195","LU0532188223.SGD","BK4600","LU1366334651.USD","LU2008162690.USD","LU0536402901.SGD","LU1868838027.USD","SG9999004360.SGD","LU0516423091.SGD","LU1048588211.SGD","IE00B7N09G41.SGD","CCM","ZLAB","LU0197229882.USD","BK4229","BK4023","SG9999014492.USD","LU0345775950.USD","LU2663582299.SGD","SIFY","CANG","LU0823038988.USD","BK4107","BK4531","SG9999005177.SGD","LU0431992006.USD","BK4557","SG9999006266.SGD","LU0499858602.USD","LU0261945553.USD","BK4007","LU0333810181.USD","BK7502","SGXZ58947870.SGD","SG9999002679.SGD","IBN","LU0287143357.SGD","LU0890818403.SGD","BK4554","LU0261950470.USD","LU1267930656.SGD","DXF","LU2065171402.SGD","LU0831103253.SGD","LU2177674079.SGD","LU0048573645.USD","SG9999002604.SGD","SG9999013486.USD","BK4566","LU0348744763.USD","BK4089","BK4551","LU1770036033.HKD","LU0181495838.USD","LU2360107671.USD","LU0516423174.USD","IE00B0JY6M65.USD","LU1102505762.USD","LPL"],"gpt_icon":1},{"id":"2616553266","title":"Skillful Craftsman Unit Signs 12-Month CSL AI Service Deal With China Auto Insurance Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2616553266","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616553266?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:31","pubTimestamp":1772631080,"startTime":"0","endTime":"0","summary":"Skillful Craftsman Education Technology Ltd. said its wholly owned subsidiary, Shenzhen Qianhai Jisen Information Technology Co., Ltd., signed an AI Technology Service and Product Sales Agreement with an auto insurance service company in China. Under the 12-month contract, Jisen will provide its self-developed Communication Skills Learning  intelligent communication assistance product and related services for employee training, customer service support, and sales script optimization. The agreement runs from Feb. 25, 2026 to Feb. 24, 2027, with monthly fees of RMB 100,000 excluding tax.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL6hnCqS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDTK","BK7511","LU2210150020.SGD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK7067","SG9999014005.SGD","LU2210149790.SGD","SG9999014013.SGD","BK7508","BK4204","SG9999014039.USD","BK4588","BK4112","BK7501","LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","CSL.AU","SG9999014021.USD"],"gpt_icon":0},{"id":"2616137072","title":"Neuren's Royalties From Daybue Sales Beat Bull's Forecast -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616137072","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616137072?lang=en_us&edition=fundamental","pubTime":"2026-03-04 07:08","pubTimestamp":1772579280,"startTime":"0","endTime":"0","summary":"2308 ET - Royalty revenue flowing to Neuren Pharmaceuticals from U.S. sales of the Daybue treatment for Rett Syndrome last year beat Macquarie's expectations. Acadia Pharmaceuticals, Neuren's partner, said U.S. net sales of Daybue totaled US$391 million in 2025. That was above the US$350 million of sales achieved in 2024. Macquarie says the sales outcome translates to A$65.0 million in royalties for Neuren, up 15% on year. This is 1.5% higher than its forecast of A$64.0 million. \"Royalty revenue ahead of expectations, driven by growth in new patient prescriptions,\" Macquarie says. \"Neuren's strong cash position enables pipeline acceleration, potentially providing significant long-term upside.\" It has an outperform call on Neuren. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","NEU.AU","BK7096"],"gpt_icon":0},{"id":"2616737103","title":"Arcturus Therapeutics Q4 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2616737103","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616737103?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:09","pubTimestamp":1772572187,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Q4 net loss narrowsOverviewmRNA medicines firm's Q4 revenue fell due to reduced CSL collaboration activityOperating expenses for Q4 decreased, driven by lower manufacturing and c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL1N3ZR192:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7067","BK7508","BK7511","ARCT","BK7501","BK4139"],"gpt_icon":0},{"id":"2616432169","title":"Analog Devices Inc Stock Opened Down by 3.38% on Mar 3: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2616432169","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616432169?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:47","pubTimestamp":1772549262,"startTime":"0","endTime":"0","summary":"• Stock trading ex-dividend on March 3, 2026, causes price adjustment.\n• CFO appearance at conference may influence trading activity and sentiment.\n• Strong Q1 results and dividend increase contrast with valuation concerns.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/stocks/261640164-market-movers-adi-20260303","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1978683503.SGD","LU0444971666.USD","LU2237443549.SGD","IE00BD6J9T35.USD","ADI","LU2298322129.HKD","IE00BZ199S13.USD","LU2275660780.HKD","LU2458330169.SGD","LU0124384867.USD","LU0077335932.USD","LU1861214812.USD","LU1670711040.USD","LU1803068979.SGD","IE0009356076.USD","ROE","LU1244550494.USD","BK4585","LU2237443978.SGD","LU0724618433.USD","LU0302445910.USD","LU2237438978.USD","LU1861219969.SGD","MOBX","BK4141","BK4605","LU2272731782.SGD","LU2458330243.SGD","BK7508","LU0109392836.USD","LU1670711123.USD","LU0312595415.SGD","OCC.AU","OCC","BK4515","LU0957808578.USD","LU1074936037.SGD","ADI.AU","SELX","BK7067","BK4561","BK4020","LU1244550577.SGD","LU1815336760.USD","LU1992135399.USD","LU2360107325.USD","LU0314104364.USD","LU1670710661.SGD","BK4588","LU1992135472.HKD"],"gpt_icon":0},{"id":"2616532165","title":"Arista Networks Inc Stock Opened Down by 3.07% on Mar 3: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532165","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616532165?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:47","pubTimestamp":1772549250,"startTime":"0","endTime":"0","summary":"• Arista Networks' share price declined due to profit-taking and valuation concerns.\n• Insider selling and NVIDIA's competition are impacting investor confidence.\n• Customer concentration and reduced institutional stakes add to selling pressure.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/stocks/261640163-market-movers-anet-20260303","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1803068979.SGD","BK7067","LU0006306889.USD","LU2355687059.USD","LU2458330243.SGD","LU0353189680.USD","LU0077335932.USD","LU2211815571.USD","OCC.AU","BK7508","IE00BMPRXQ63.HKD","MOBX","BK4141","SG9999001424.SGD","BK4588","LU2286300806.USD","OCC","SELX","IE00BMPRXN33.USD","ANET","BK4543","LU0106261372.USD","LU0353189763.USD","LU0109392836.USD","LU2458330169.SGD","LU0889565833.HKD","IE00BN0W2W23.USD","LU0348723411.USD","LU0557290698.USD","BK4539","LU1917777945.USD","IE00BN0W2T93.GBP","LU2054465674.USD","LU2023250504.SGD","BK4554","IE00BN0W2V16.EUR","LU1974910355.USD","IE00BMPRXR70.SGD","BK4020","LU2087625088.SGD","LU0225283273.USD","LU2106854487.HKD","LU0198837287.USD","LU2108987350.USD","BK4585","IE0008368304.USD"],"gpt_icon":0},{"id":"2616286483","title":"PAR Technology Launches Artificial Intelligence Suite for Convenience Retailers","url":"https://stock-news.laohu8.com/highlight/detail?id=2616286483","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616286483?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:10","pubTimestamp":1772543448,"startTime":"0","endTime":"0","summary":"PAR Technology  said Tuesday it has launched an artificial intelligence-powered product suite designed to provide real-time data insights and automate operations for convenience and fuel retailers.The new platform integrates directly into PAR's existing systems to reduce manual effort and eliminate the need for third-party applications, the company said.The software features modules that allow operators to generate data charts through a chat interface, automatically build promotional campaigns, and develop strategic plans using historical performance and external weather data, PAR said.Shares of the company were down 1.7% in recent Tuesday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PAR.AU","PAR","BK4023","BK4157","BK7067","BK7508"],"gpt_icon":0},{"id":"2616316503","title":"Pfisterer posts FY 2025 order backlog of EUR 335 million, up more than 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616316503","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616316503?lang=en_us&edition=fundamental","pubTime":"2026-03-03 15:01","pubTimestamp":1772521268,"startTime":"0","endTime":"0","summary":"PFISTERER posted preliminary unaudited FY 2025 results showing sales of about EUR 450 million  and adjusted EBITDA of about EUR 80 million . Order intake rose to just under EUR 550 million , lifting the order backlog to nearly EUR 335 million  as of Dec. 31, 2025. Adjusted operating cash flow increased to about EUR 58 million , while investments rose to more than EUR 38 million, primarily to expand capacities, build an HVDC laboratory and complete the acquisition of Power CSL. Q4 2025 sales were about EUR 120 million . The company said final audited FY 2025 figures and a 2026 outlook are due on April 15, 2026, and reiterated its strategic focus on capacity expansion, global presence and HVDC-related innovation.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL5QCLn2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7508","BK7501","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2616925273","title":"BUZZ-Australia's Neuren Pharmaceuticals drops as US partner seeks EMA re-examination","url":"https://stock-news.laohu8.com/highlight/detail?id=2616925273","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616925273?lang=en_us&edition=fundamental","pubTime":"2026-03-03 11:53","pubTimestamp":1772510032,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Neuren Pharmaceuticals drops as US partner seeks EMA re-examination** Shares of Neuren Pharmaceuticals NEU.AX fall 8% to A$12.67, on track for their weakest session since February 5** The biopharma firm says its partner, Acadia Pharmaceuticals ACAD.O, confirms plan to request re-examination of opinion adopted by Committee for Medicinal Products for Human Use of the European Medicines Agency ** Re-examination regarding the marketing of trofinetide for the treatment of Rett syndrome in patients two years and older - co** Australian healthcare stocks .AXHJ down 1.5%, in line with broader benchmark .AXJO which is down 1.2%** YTD, stock down 31.9%, including the day's move  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL4N3ZR0BD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","BK7508","LU2065169927.USD","BK4139","NEU.AU","LU2065171402.SGD","BK7096","ACAD","LU2065170008.USD"],"gpt_icon":0},{"id":"2616609843","title":"Neuren Partner Plans to Request Re-examination of European Authority's Opinion on Trofinetide Marketing Authorization Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2616609843","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616609843?lang=en_us&edition=fundamental","pubTime":"2026-03-03 07:36","pubTimestamp":1772494615,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  said its partner, Acadia Pharmaceuticals, confirmed that it plans to request a re-examination of the European Medicines Agency's Committee for Medicinal Products for Human Use's opinion regarding the marketing authorization application for trofinetide for the treatment of Rett syndrome in patients aged two years and older, according to a Tuesday Australian bourse filing.The committee issued a refusal, saying that the treatment effect observed with trofinetide after 12 weeks, while measurable, was viewed as limited in magnitude, that the Lavender clinical trial did not capture all core symptoms of Rett syndrome, and that the assessment of longerterm outcomes was influenced by patient discontinuations over time.Trofinetide is approved in the US, Canada, and Israel, per the filing.Neuren Pharmaceuticals' shares fell 5% in early trading on Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","NEU.AU","BK7096"],"gpt_icon":0},{"id":"2616333591","title":"Immuron HY26 net loss narrows 22.9% to AUD 1.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616333591","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616333591?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:10","pubTimestamp":1772449801,"startTime":"0","endTime":"0","summary":"Immuron reported HY26 revenue from ordinary activities of AUD 4.2 million, up 4.8%, and a loss after tax attributable to shareholders of AUD 1.9 million, down 22.9%, for the six months ended 31 December 2025. Net tangible assets were 3.94 cents per share at 31 December 2025. The company ended the half with cash and cash equivalents of AUD 10.0 million and net assets of AUD 13.1 million. Operationally, Immuron highlighted record HY26 sales of AUD 4.2 million , including Travelan sales growth in Australia to AUD 3.2 million  and in the US to AUD 0.9 million , while Canada Travelan sales declined to AUD 0.1 million. Key updates included FDA approval of the IMM-529 investigational new drug application for a Phase 2 trial in Clostridioides difficile infection, a new US Department of Defense award to develop oral therapeutics targeting Campylobacter and Shigella, release of topline data from a Uniformed Services University trial of a third-party manufactured IMM-124E product, and the launch ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLbT1rRh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMC.AU"],"gpt_icon":0},{"id":"2616038420","title":"Indonesia's Soekarno-Hatta Reschedules 39 Middle East Flights","url":"https://stock-news.laohu8.com/highlight/detail?id=2616038420","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616038420?lang=en_us&edition=fundamental","pubTime":"2026-03-02 16:10","pubTimestamp":1772439012,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-The Soekarno-Hatta International Airport  Branch Office of PT Angkasa Pura Indonesia  in Tangerang, Banten, adjusted the departure schedules of 39 flights to the Middle East that had been postponed due to the conflict in the region.Aziz Fahmi Harahap, the Acting Assistant Deputy for Communication and Legal Affairs at Soekarno-Hatta International Airport, said on Monday in Tangerang that, as of 10:00 AM local time, there were 39 scheduled flights on the Middle East route. This consisted of 20 arrivals and 19 departures, including 38 regular flights and one charter flight.\"Following up on developments in flight operations on the Middle East route, we are reporting this based on route permit data issued by the relevant authorities and updated as of 10:00 AM LT,\" he said.","market":"fut","thumbnail":"https://statik.tempo.co/data/2025/12/23/id_1449385/1449385_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/12/23/id_1449385/1449385_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2090117/indonesias-soekarno-hatta-reschedules-39-middle-east-flights","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2090117/indonesias-soekarno-hatta-reschedules-39-middle-east-flights","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7508","BK4532","DXB","BK7067","DXB.AU","MED.AU","MED","BK7501","BK4183"],"gpt_icon":0},{"id":"2616338779","title":"How Investors May Respond To Neuren Pharmaceuticals (ASX:NEU) 2025 Results, Buy-Back Plan And Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2616338779","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616338779?lang=en_us&edition=fundamental","pubTime":"2026-03-02 15:13","pubTimestamp":1772435590,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals recently reported its full-year 2025 results, with revenue of A$84.84 million and net income of A$30.44 million, alongside a trading pause on the ASX pending a market-sensitive announcement.\nDespite lower year-on-year earnings, Neuren highlighted increased DAYBUE royalties, a new share buy-back program, and progress in its NNZ-2591 pipeline, including an FDA Fast Track designation, underscoring the company’s focus on advancing its rare neurological disorder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-neu/neuren-pharmaceuticals-shares/news/how-investors-may-respond-to-neuren-pharmaceuticals-asxneu-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-neu/neuren-pharmaceuticals-shares/news/how-investors-may-respond-to-neuren-pharmaceuticals-asxneu-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","NEU","BK4097","ISBC","LU2065732104.USD","NEU.AU","BK7096","BK4211","PRGS","BK4109"],"gpt_icon":0},{"id":"2616992802","title":"Opthea Swings to Fiscal H1 Earnings, Posts Lower Revenue, Plans to Rename","url":"https://stock-news.laohu8.com/highlight/detail?id=2616992802","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616992802?lang=en_us&edition=fundamental","pubTime":"2026-03-02 13:16","pubTimestamp":1772428581,"startTime":"0","endTime":"0","summary":"Opthea (ASX:OPT) reported Monday fiscal first-half earnings of AU$0.2552 per share, compared to a loss of AU$0.1650 a year earlier.Revenue for the six months ended Dec. 31, 2025, was AU$1,000, compare","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPT.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2616804550","title":"Organic Growth in Australia's Healthcare Services Likely Due to Increased Availability of Bulk-Billing General Practitioners, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2616804550","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616804550?lang=en_us&edition=fundamental","pubTime":"2026-03-02 12:27","pubTimestamp":1772425659,"startTime":"0","endTime":"0","summary":"An organic growth in Australian healthcare services is likely due to improving availability of bulk-billing general practitioners, offset by ongoing wage pressures, Jefferies said in a Monday report.I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","HLS.AU","BK7509","XBI","NEU.AU","ANN.AU","BK4581","MVF.AU","XLV","SHL.AU","BK4588","HCAR","XKO.AU","BK7089","XAO.AU","SIG.AU","BK7501","BK4585","CSL.AU","BK7067","BK7113","REG.AU","RHC.AU","BK7007","BK7124","BK7103","IDX.AU","MSB.AU","CUV.AU","BK7096","COH.AU","IMM.AU","MPL.AU","BK7508","BK7511","CU6.AU","TLX.AU","NHF.AU","XJO.AU","FPH.AU","LABU"],"gpt_icon":0},{"id":"2616874093","title":"Anagenics Ltd-an1 - Director Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2616874093","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616874093?lang=en_us&edition=fundamental","pubTime":"2026-03-02 06:49","pubTimestamp":1772405357,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260301:nTUENHPK3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AN1.AU","BK7508","BK7111"],"gpt_icon":0},{"id":"2616978871","title":"Opthea Ltd H1 Net Income AUD 339.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616978871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616978871?lang=en_us&edition=fundamental","pubTime":"2026-03-02 05:16","pubTimestamp":1772399762,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260301:nPLXE92F98:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","OPT.AU","BK7508"],"gpt_icon":0},{"id":"2616822766","title":"17 Jakarta-Mideast Flights Canceled Due to Airspace Closure; Here's the List","url":"https://stock-news.laohu8.com/highlight/detail?id=2616822766","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616822766?lang=en_us&edition=fundamental","pubTime":"2026-03-01 18:39","pubTimestamp":1772361543,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-A total of 17 flights from Soekarno-Hatta International Airport in Cengkareng to the Middle East were canceled on Sunday, March 1, 2026. This follows the closure of airspace in several Middle Eastern countries after attacks on Iran by the United States and Israel.\"As of the latest update, 17 flights have been confirmed as canceled,\" said Aziz Fahmi Harahap, Acting Assistant Deputy of Communication and Legal at Soekarno-Hatta International Airport, on Sunday, March 1, 2026.Fahmi stated that, based on route permits issued by relevant authorities and updates as of 10:00 a.m. Jakarta time, a total of 39 scheduled flights to the Middle East were recorded today, consisting of 20 arrivals and 19 departures. \"This comprises 38 regular flights and one charter flight,\" Fahmi noted.","market":"sh","thumbnail":"https://statik.tempo.co/data/2025/10/28/id_1437652/1437652_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/10/28/id_1437652/1437652_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2089966/17-jakarta-mideast-flights-canceled-due-to-airspace-closure-heres-the-list","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2089966/17-jakarta-mideast-flights-canceled-due-to-airspace-closure-heres-the-list","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7067","BK4183","DXB","BK7508","DXB.AU","MED.AU","MED","BK4532","BK7501"],"gpt_icon":0},{"id":"2616260638","title":"Four Flights at Bali Airport Affected by US Attack on Iran","url":"https://stock-news.laohu8.com/highlight/detail?id=2616260638","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616260638?lang=en_us&edition=fundamental","pubTime":"2026-03-01 11:20","pubTimestamp":1772335251,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-The impact of the United States and Israel attack on Iran is starting to be felt in Bali. Several flights from Bali's Ngurah Rai Airport have been delayed and rescheduled.\"This is due to the closure of airspace in several countries,\" said airport spokesperson Gede Eka Sandi Asmadi on Saturday evening, February 28, 2026.However, he emphasized that flight operations and airport services at I Gusti Ngurah Rai International Airport in Bali are generally operating normally.","market":"nz","thumbnail":"https://statik.tempo.co/data/2025/09/02/id_1425548/1425548_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/09/02/id_1425548/1425548_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2089895/four-flights-at-bali-airport-affected-by-us-attack-on-iran","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2089895/four-flights-at-bali-airport-affected-by-us-attack-on-iran","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["DXB.AU","BK7501","DXB","BK7508","BK7067"],"gpt_icon":0},{"id":"2616447198","title":"Neuren Pharmaceuticals FY 2025 Margin Strength Tests Earnings Quality Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2616447198","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616447198?lang=en_us&edition=fundamental","pubTime":"2026-03-01 05:29","pubTimestamp":1772314142,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals (ASX:NEU) has opened FY 2025 with first half revenue of A$28.3 million and basic EPS of A$0.12, setting a different tone from the prior half, when the company recorded A$192.5 million of revenue and basic EPS of A$1.05. The company has seen revenue move from A$26.2 million and basic EPS of A$0.06 in the first half of FY 2024 to A$28.3 million and A$0.12 in the latest period. Trailing twelve month EPS sits at A$1.17 on revenue of A$218.9 million, giving investors a clear...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-neu/neuren-pharmaceuticals-shares/news/neuren-pharmaceuticals-fy-2025-margin-strength-tests-earning","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-neu/neuren-pharmaceuticals-shares/news/neuren-pharmaceuticals-fy-2025-margin-strength-tests-earning","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BK7096","NEU.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":103,"code":"91000000","status":"200"}]}}